Navigation Links
State, National Long Term Care Community Applauds Arkansas Leaders in U.S. Senate and U.S. House for Helping Lead Effort to Block $770 Million Bush Medicare Cuts
Date:7/2/2008

Bipartisan Efforts Oppose $6.5 Million Funding Cut to State's Medicare Beneficiaries

LITTLE ROCK, Ark., July 2 /PRNewswire-USNewswire/ -- The Arkansas Health Care Association and the American Health Care Association (AHCA) today praised Senators Blanche Lincoln (D) and Mark Pryor (D) and Representatives Marion Berry (D-1st), Vic Snyder (D-2nd), John Boozman (R-3rd) and Mike Ross (D-4th) for helping lead efforts in the U.S. Senate and U.S. House of Representatives to prevent the Bush Administration from moving forward with regulatory-driven cuts to seniors' Medicare Part A nursing home funding -- cuts that will result in Arkansas' seniors losing $6.5 million in the year ahead.

Specifically, Sens. Lincoln and Pryor and Reps. Berry, Snyder, Boozman and Ross joined Sens. Norm Coleman (R-MN) and Kent Conrad (D-ND) and U.S. Reps. Earl Pomeroy (D-ND) and Shelley Moore Capito (R-WV) in a letter issued to Health and Human Services (HHS) Secretary Mike Leavitt. The letter expresses their "deep concern" that high-quality skilled nursing care for America's seniors will be threatened if the Centers for Medicare and Medicaid Services (CMS) moves forward with an administrative proposal -- in the coming weeks -- that would cut $770 million in Medicare funding for skilled nursing facility (SNF) care in 2009 and more than $4 billion over the next five years.

"It is highly significant that our state's leaders in Washington have joined the efforts in the U.S. Senate and U.S. House to speak out and oppose the Bush Administration's damaging Medicare funding reductions, and on behalf of Arkansas' Medicare beneficiaries and the providers who care for them, we thank them for doing so," said Randy Wyatt, Executive Vice President of the Arkansas Health Care Association. "These policymakers have objectively evaluated how these cuts will hurt Arkansas' Medicare beneficiaries, and are acting upon that determination to protect their elderly constituents."

Bruce
'/>"/>

SOURCE Arkansas Health Care Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. State, National Long Term Care Community Applauds New Hampshire Leader in U.S. Senate for Helping Lead Effort to Block $770 Million Bush Medicare Cuts
2. Pennsylvania Attorney General Corbett Announces a Multi-state, $58 Million Settlement With Merck Over Deceptive Advertising Concerning the Safety of Vioxx
3. Large Disparities in Kidney Testing Based on Disease, Gender and State, Quest Diagnostics Health Trends(TM) Report Finds
4. TRIZCON2008 at Kent State, April 13-15
5. Report Lists Key Policy Questions Facing State, National Health Reform
6. Researchers investigate links between prostate, cadmium, zinc
7. Intel Co-Founder Andrew S. Grove Dedicates Portion of His Estate, Up to $40 Million, to Michael J. Fox Foundation
8. Marin County Scandal and Elder Abuse Horror: Lawsuits Link Death Nurse, Bay Area lawyers, Doctor and Blind Eye by Local, State, and National Public Officials
9. FGX International to Present at the Oppenheimer 8th Annual Consumer Growth Conference
10. 2008 International Federation of Adipose Therapeutics and Science (IFATS) Conference Date Set
11. Syndicated Radio Personality Ebony Steele Arrington Continues the Fight Against Breast Cancer as National Ambassador for Susan G. Komen for the Cure(R)s Circle of Promise

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... Pilots will enable local organizations to t...er for consumers who lack access , ...men Fund, a nonprofit venture firm addressing pove...it has selected four organizations in Kenya to con...r transportation and storage. , , ,The pilot progr...
(Date:12/1/2009)..., LONDON, Dec. 1 Lucrative opportu...s patient monitoring devices market, particularly ...his segment is growing at a rapid pace. The primar...s among an ageing population about devices that he...erly prefer to age at home - a trend supported by ...
(Date:12/1/2009)... Dec. 1 /PRNewswire/ - Sentinelle Medical Inc., a ...vanced visualization software, extends its line of...gical Society of North America (RSNA) annual meeti... Hall A). ,, With the unique Vanguard(R) patien...metry(TM), Sentinelle,s line of breast coils are r...
(Date:12/1/2009)... NYC based physician Dr. Michael Aziz announ...;The Perfect 10 Diet: 10 Key Hormones that Hold th..." (Source books Jan. 2110). The book deliver...pular diets disturb hormones, and promises a drama...alancing hormones. , New ...
(Date:12/1/2009)... Amadeus will operate as a division of Xybio...olls, NJ (PRWEB) December 1, 2009 -- Xybion Corpor...quisition of all operating assets of Quebec City b...t of enterprise governance, risk, compliance and q..., a corporate performance management organization ...
Breaking Medicine News(10 mins):Health News:Acumen Fund Announces Ripple Effect Pilot Projects In Kenya To Identify Innovative Solutions To Water Challenges 2Health News:Acumen Fund Announces Ripple Effect Pilot Projects In Kenya To Identify Innovative Solutions To Water Challenges 3Health News:Acumen Fund Announces Ripple Effect Pilot Projects In Kenya To Identify Innovative Solutions To Water Challenges 4Health News:Ageing Demographic Boosts Uptake of Wireless Patient Monitoring Devices Across Europe, Finds Frost & Sullivan 2Health News:Ageing Demographic Boosts Uptake of Wireless Patient Monitoring Devices Across Europe, Finds Frost & Sullivan 3Health News:Sentinelle Medical Introduces New Suite of Breast MRI Coils for GE, Siemens and Toshiba Scanners 2Health News:Sentinelle Medical Introduces New Suite of Breast MRI Coils for GE, Siemens and Toshiba Scanners 3Health News:Dr. Michael Aziz Releases a New Nutrition Book That Debunks Most Popular Diets and Diet Books 2Health News:Dr. Michael Aziz Releases a New Nutrition Book That Debunks Most Popular Diets and Diet Books 3Health News:Xybion Acquires Amadeus, a Leader in Governance, Risk, Compliance and Quality Management (GRC) Solutions 2Health News:Xybion Acquires Amadeus, a Leader in Governance, Risk, Compliance and Quality Management (GRC) Solutions 3
...d's loss to Argentina in a World Cup match in 1998...ttack rates by 27 per cent. The fact that extreme ...ulnerable people is known to almost everyone.Howev...e that hospital admissions for heart attack, stro...
...is received approval from the Food and Drug Admini...nkiller, which will be used to relieve post-operat...vartis facility at Puerto Rico //is the result of ...ties. The marketing campaign for the drug was...
... fish at least once a month can minimise the risk ...d researchers. Around 607 participants deve...w study involving more than 43,005 men aged 39 to ...ere confirmed as hemorrhagic stroke, caused by a l...
...chers at the Medical college of Wisconsin have rec...otective reflexes in the throat area. A one-way va...hroat and smoking causes damage to the// pharyngog...mokers were tested by imaging the relex area befor...
...ing to a recent study researchers have observed th...en though painful, is the best way forward in peri...hose aged 55// or over will be affected by periphe... this situation, you would think walking would be ...
... who are specialzed with specific skills do home c...sease. Chronic bronchitis and emphysema - or chron...ery disabling, because of breathlessness and impai...e home setting cuts costs, re-admission to hospita...
Other Medicine News:
(Date:12/1/2009)...c. 1 /PRNewswire-Asia-FirstCall/ -- Tianyin,Pharma...urer and supplier of,modernized traditional Chines...announced that it has received approvals from the ...to produce Pediatric Fever and Cough Oral Liquid i...Z20093060) and Antibacterial,and Anti-inflammatory...
(Date:12/1/2009)...ewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (...eriod has expired under the Hart-Scott-Rodino (HSR...to Vanda,s agreement, dated October 12, 2009, with... effective. Expiration of the waiting period, and...ggers an upfront payment to Vanda of $200 million....
(Date:12/1/2009)...wire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI )...oprietary antibodies for the treatment of cancer, ...ed that Bayer Schering Pharma AG has exercised its...e agreement entered into on January 12, 2009 to de...id tumors. ,, Under the terms of the agreement,...
Breaking Medicine Technology:Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA New Product Approvals for 2 Generic Products 2Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA New Product Approvals for 2 Generic Products 3Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 2Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 3Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 4Red Cross Implements Change to Enhance Donor Safety for Younger Donors 59824 1Red Cross Implements Change to Enhance Donor Safety for Younger Donors 59824 2The Advisory Board Company Schedules Second Quarter Conference Call for November 2 2009 59822 1The Advisory Board Company Schedules Second Quarter Conference Call for November 2 2009 59822 2IntraHealth to Lead 24300 Million USAID Project in Global Health Workforce Systems Strengthening 59820 1IntraHealth to Lead 24300 Million USAID Project in Global Health Workforce Systems Strengthening 59820 2
...onstrated Sustained Improvement in Signs and,Sympt...h One-Third,of Patients Achieving Disease Remiss...007 – One-year data show nearly,75 percent o...ritis,(RA) receiving golimumab (CNTO 148) and meth... 20 percent improvement in,arthritis symptoms (ACR...
...ain, June 15, 2007 /PRNewswire-FirstCall/ --,Brist...garding the,efficacy and safety of ORENCIA(R) (aba...vestigational study in children with juvenile,idio...response to,one or more disease-modifying anti- rh... or tumor necrosis factor (TNF) antagonists.,The r...
Other Medicine Technology:Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid,Arthritis Study 2Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid,Arthritis Study 3Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid,Arthritis Study 4Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid,Arthritis Study 5Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 2Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 3Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 4Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 5Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 6
...ies I Instrument program offers state-of-the-art q...while maintaining strength and durability. Low pro...ht joint spaces. Series I instruments are availabl...angle required for large and small joint arthrosco...
...ies I Instrument program offers state-of-the-art q...while maintaining strength and durability. Low pro...ht joint spaces. Series I instruments are availabl...angle required for large and small joint arthrosco...
...ies I Instrument program offers state-of-the-art q...while maintaining strength and durability. Low pro...ht joint spaces. Series I instruments are availabl...angle required for large and small joint arthrosco...
...ies I Instrument program offers state-of-the-art q...while maintaining strength and durability. Low pro...ht joint spaces. Series I instruments are availabl...angle required for large and small joint arthrosco...
Medicine Products: